𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk for thrombosis linked to the target antigen of a lupus anticoagulant?

✍ Scribed by J. Arnout

Book ID
109148384
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
77 KB
Volume
2
Category
Article
ISSN
1538-7933

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Systemic lupus erythematosus in a multie
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients
✍ Jaime Calvo-AlΓ©n; Sergio M. A. Toloza; MΓ³nica FernΓ‘ndez; Holly M. Bastian; Barri πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a

Comorbidities and the willingness to pay
Comorbidities and the willingness to pay for reducing the risk of a targeted disease: introducing endogenous effort for risk reduction
✍ Liqun Liu πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract Previous studies demonstrated that the willingness to pay (WTP) for reducing the risk of a targeted disease increases with the severity of a comorbidity condition. They evaluated the WTPs at positions where otherwise identical individuals who have unequal comorbidity conditions all have